Details of the Drug
General Information of Drug (ID: DMH4IRP)
Drug Name |
2-(thiazol-4-yl)-1H-benzo[d]imidazol-5-amine
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
1H-Benzimidazol-5-amine, 2-(4-thiazolyl)-; CHEMBL370420; 25893-06-5; 5-Aminothiabendazole; 5-amino-2-(thiazol-4-yl)-1H-benzimidazole; 2-(4-Thiazolyl)-1H-benzimidazol-5-amine; AC1Q4XVD; 2-(thiazol-4-yl)-1H-benzo[d]imidazol-5-amine; AC1L35H8; SCHEMBL4367564; CTK7D8516; CUDHOGCHOXYXRZ-UHFFFAOYSA-N; MolPort-004-293-518; ZINC13679482; BDBM50180749; AKOS000129404; MCULE-2929987645; 5-amino-2-thiazol-4-yl-1H-benzoimidazole; 2-Thiazol-4-yl-3H-benzoimidazol-5-ylamine; 2-(1,3-thiazol-4-yl)-3H-benzimidazol-5-amine
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure |
![]() |
||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 216.26 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 1.8 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||